Main highlights of the January-March 2012 results
§ +13% in growth in consolidated revenues, amounting to €177.9 million, underpinned by strong volumes.
§ +9% year-on-year consolidated EBITDA growth to €42.8 million.
§ +6% year-on-year net profit growth to €23.3 million.
§ Works continue to build the new collagen extrusion plant in China, which is expected to be started up in the first quarter of 2013.
§ Net financial debt stands at €61.1 million, 0.5% down on the December figure, despite the investments made in the first quarter of the year.
For more information please click here: